Summary
CVS Health Corporation announced the issuance and sale of $2.0 billion in aggregate principal amount of senior notes. This includes a $750 million issuance of 1.300% Senior Notes due 2027, which will be fungible with the existing notes issued in August 2020, and a $1.25 billion issuance of 1.875% Senior Notes due 2031. The company expects to close the sale on December 16, 2020. This debt offering is significant as it provides CVS Health with approximately $1.986 billion in net proceeds, after deducting underwriting discounts and offering expenses. Investors should note that this move is a capital-raising activity, and the specific use of these proceeds is not detailed in this particular filing, though it typically supports ongoing operations, strategic initiatives, or refinancing existing debt. The offering was made under the company's effective shelf registration statement.
Key Highlights
- 1CVS Health is issuing $2.0 billion in new senior notes.
- 2The issuance comprises $750 million of 1.300% Senior Notes due 2027 and $1.25 billion of 1.875% Senior Notes due 2031.
- 3The 2027 notes are an additional issuance and will be fungible with existing 2027 notes.
- 4The expected closing date for the sale is December 16, 2020.
- 5Net proceeds from the offering are estimated to be approximately $1.986 billion.
- 6The offering is conducted under the company's existing Form S-3ASR registration statement.